Moatti Jean Paul
UFR de sciences économiques & gestion, UMR INSERM/IRD/Université de la Méditerranée 912, Sciences économiques & sociales, systèmes de santé, sociétés, faculté de sciences économiques, Aix en Provence, France.
C R Biol. 2008 Dec;331(12):964-72. doi: 10.1016/j.crvi.2008.08.014. Epub 2008 Oct 21.
Since the start of the new century, development aid targeted on health care has seen an unprecedented rise, driven by the fight against AIDS. This article shows how this struggle has been accompanied with a renewal of the economic paradigms governing international action in favour of health care in developing countries: the idea that an improvement in health care constitutes an unavoidable prerequisite to macroeconomic growth, rather than a consequence; the insistence on the founding of mechanisms for health insurance to finance the costs of health care, rather than covering the costs at the point of use by the health care users; a concern to impose price differentials for access to medicine in developing countries, and to introduce flexibility in the regulation of international intellectual property law; the priority to vertical programmes targeted on certain illnesses, thought to act as levers for a global reinforcement of health care systems. This article discusses the pertinence of these new paradigms in light of the evolution of the AIDS/HIV epidemic, and the international context.
自新世纪伊始,在抗击艾滋病的推动下,针对医疗保健的发展援助呈现出前所未有的增长。本文展示了这场斗争如何伴随着经济范式的更新,这些范式主导着有利于发展中国家医疗保健的国际行动:即认为改善医疗保健是宏观经济增长不可避免的先决条件,而非结果;坚持建立医疗保险机制以支付医疗保健费用,而非在医疗保健使用者使用时支付费用;关注在发展中国家实行药品获取价格差异,并在国际知识产权法监管中引入灵活性;优先开展针对某些疾病的垂直项目,认为这些项目可作为全球加强医疗保健系统的杠杆。本文根据艾滋病/艾滋病毒疫情的演变及国际背景,探讨了这些新范式的相关性。